알지노믹스

476830KOSDAQSector: Pharma & Biotech

₩25,850▼ 12.52%Market cap ₩725.2BAs of Jul 21, 2026 close · updated once daily

Grade D36.2 ptsTop 76% of 2,523 stocks

Financial strength

53.1

Price attractiveness

16.9

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

ⓘ Growth momentum not rated — will be included automatically as data accumulates

Financial strength

53.1

How much debt does it carry relative to equity?

Debt-to-equity ratio

6.7%

✓ Above median · Top 7.1% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

1829.1%

✓ Above median · Top 5.5% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-184.3%

✗ Below median · Top 79.6% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-176.3%

✗ Below median · Top 95.3% in sector

Sector median -4.5%

Source filing: annual report (separate) — view original ↗

Growth momentum

Did core profits grow in a year?

Operating income change (YoY)

-13.5%

✗ Below median · Top 65.8% in sector

Sector median 3.6%

Source filing: annual report (separate) — view original ↗

Price attractiveness

16.9

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 77% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

12.32x

✗ Below median · Top 89.2% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15